 Data show DetermaIOTM may help to select effective therapeutic options for immune checkpoint inhibitor ICI resistant patients with non-small cell lung cancer NSCLC and triple-negative breast cancer TNBC Data show DetermaIOTM may help to select effective therapeutic options for immune checkpoint inhibitor ICI resistant patients with non-small cell lung cancer NSCLC and triple-negative breast cancer TNBC 